• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇在肺部的抗炎和抗纤维化作用。

Anti-inflammatory and antifibrotic effects of resveratrol in the lung.

作者信息

Conte Enrico, Fagone Evelina, Fruciano Mary, Gili Elisa, Iemmolo Maria, Vancheri Carlo

机构信息

Department of Clinical and Molecular Biomedicine, University of Catania, Italy.

出版信息

Histol Histopathol. 2015 May;30(5):523-9. doi: 10.14670/HH-30.523. Epub 2014 Dec 16.

DOI:10.14670/HH-30.523
PMID:25515609
Abstract

Resveratrol, a natural polyphenolic molecule with several biological activities, is a well recognized anti-oxidant, anti-aging and cancer chemopreventive agent. Moreover, resveratrol anti-inflammatory and antifibrotic properties have been demonstrated both in vitro and in different animal models of inflammatory pathologies, including bowel and liver diseases. We review the evidence of resveratrol protective role in respiratory diseases such as acute lung injury, asthma, chronic obstructive pulmonary disease and lung fibrosis. We conclude that resveratrol and its derivatives may act as a therapeutic agents in respiratory diseases and pertinent clinical trials should be performed.

摘要

白藜芦醇是一种具有多种生物活性的天然多酚分子,是一种公认的抗氧化、抗衰老和癌症化学预防剂。此外,白藜芦醇的抗炎和抗纤维化特性已在体外以及包括肠道和肝脏疾病在内的不同炎症性疾病动物模型中得到证实。我们综述了白藜芦醇在急性肺损伤、哮喘、慢性阻塞性肺疾病和肺纤维化等呼吸系统疾病中保护作用的证据。我们得出结论,白藜芦醇及其衍生物可能作为呼吸系统疾病的治疗剂,应开展相关临床试验。

相似文献

1
Anti-inflammatory and antifibrotic effects of resveratrol in the lung.白藜芦醇在肺部的抗炎和抗纤维化作用。
Histol Histopathol. 2015 May;30(5):523-9. doi: 10.14670/HH-30.523. Epub 2014 Dec 16.
2
Antioxidant and anti-inflammatory effects of resveratrol in airway disease.白藜芦醇在气道疾病中的抗氧化和抗炎作用。
Antioxid Redox Signal. 2010 Nov 15;13(10):1535-48. doi: 10.1089/ars.2009.3064.
3
Design, synthesis and biological evaluation of paralleled Aza resveratrol-chalcone compounds as potential anti-inflammatory agents for the treatment of acute lung injury.平行氮杂白藜芦醇-查尔酮化合物作为治疗急性肺损伤的潜在抗炎剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2015 Aug 1;25(15):2998-3004. doi: 10.1016/j.bmcl.2015.05.030. Epub 2015 May 19.
4
Development of resveratrol-curcumin hybrids as potential therapeutic agents for inflammatory lung diseases.白藜芦醇 - 姜黄素杂合物作为炎症性肺病潜在治疗剂的开发。
Eur J Med Chem. 2017 Jan 5;125:478-491. doi: 10.1016/j.ejmech.2016.09.033. Epub 2016 Sep 10.
5
Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice.多酚对小鼠实验性肺纤维化相关炎症过程的保护作用。
Br J Nutr. 2015 Sep 28;114(6):853-65. doi: 10.1017/S0007114515002597.
6
Statins in the treatment of COPD and asthma-where do we stand?他汀类药物在 COPD 和哮喘治疗中的应用——我们处于什么位置?
Curr Opin Pharmacol. 2018 Jun;40:26-33. doi: 10.1016/j.coph.2018.01.001. Epub 2018 Jan 13.
7
Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases.白藜芦醇在眼部疾病中的抗氧化、抗炎和抗血管生成特性
Molecules. 2016 Mar 2;21(3):304. doi: 10.3390/molecules21030304.
8
Resveratrol attenuates hyperoxia-induced oxidative stress, inflammation and fibrosis and suppresses Wnt/β-catenin signalling in lungs of neonatal rats.白藜芦醇可减轻新生大鼠肺部高氧诱导的氧化应激、炎症和纤维化,并抑制Wnt/β-连环蛋白信号通路。
Clin Exp Pharmacol Physiol. 2015 Oct;42(10):1075-83. doi: 10.1111/1440-1681.12459.
9
Resveratrol attenuates spinal cord injury-induced inflammatory damage in rat lungs.白藜芦醇减轻大鼠脊髓损伤诱导的肺部炎症损伤。
Int J Clin Exp Pathol. 2015 Feb 1;8(2):1237-46. eCollection 2015.
10
Resveratrol as a potential therapeutic drug for respiratory system diseases.白藜芦醇作为呼吸系统疾病的一种潜在治疗药物。
Drug Des Devel Ther. 2017 Dec 15;11:3591-3598. doi: 10.2147/DDDT.S148868. eCollection 2017.

引用本文的文献

1
Synergistic anticancer activity of resveratrol-loaded polymeric nanoparticles and sunitinib in colorectal cancer treatment.负载白藜芦醇的聚合物纳米颗粒与舒尼替尼在结直肠癌治疗中的协同抗癌活性。
R Soc Open Sci. 2025 Apr 23;12(4):241817. doi: 10.1098/rsos.241817. eCollection 2025 Apr.
2
Research progress of SIRTs activator resveratrol and its derivatives in autoimmune diseases.SIRTs 激活剂白藜芦醇及其衍生物在自身免疫性疾病中的研究进展。
Front Immunol. 2024 Jun 19;15:1390907. doi: 10.3389/fimmu.2024.1390907. eCollection 2024.
3
Landscape analysis and overview of the literature on oxidative stress and pulmonary diseases.
氧化应激与肺部疾病的文献综述及景观分析
Front Pharmacol. 2023 May 26;14:1190817. doi: 10.3389/fphar.2023.1190817. eCollection 2023.
4
Electrochemical Quantification of HO Released by Airway Cells Growing in Different Culture Media.在不同培养基中生长的气道细胞释放的HO的电化学定量分析。
Micromachines (Basel). 2022 Oct 18;13(10):1762. doi: 10.3390/mi13101762.
5
Resveratrol in the treatment of asthma based on an animal model.基于动物模型的白藜芦醇治疗哮喘研究
Postepy Dermatol Alergol. 2022 Jun;39(3):433-438. doi: 10.5114/ada.2022.117543. Epub 2022 Jul 15.
6
Histopathological, physiological and biochemical assessment of resveratrol nanocapsules efficacy in bleomycin-induced acute and chronic lung injury in rats.白藜芦醇纳米胶囊对博莱霉素诱导的大鼠急性和慢性肺损伤的组织病理学、生理学和生物化学评估。
Drug Deliv. 2022 Dec;29(1):2592-2608. doi: 10.1080/10717544.2022.2105445.
7
Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.将氧化应激作为特发性肺纤维化的一种治疗方法
Front Pharmacol. 2022 Jan 21;12:794997. doi: 10.3389/fphar.2021.794997. eCollection 2021.
8
Friend or Foe? The Roles of Antioxidants in Acute Lung Injury.敌友难辨?抗氧化剂在急性肺损伤中的作用
Antioxidants (Basel). 2021 Dec 7;10(12):1956. doi: 10.3390/antiox10121956.
9
Aberrant Methylation of Aging-Related Genes in Asthma.哮喘中衰老相关基因的异常甲基化
Front Mol Biosci. 2021 May 25;8:655285. doi: 10.3389/fmolb.2021.655285. eCollection 2021.
10
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies.与Nrf2相互作用的营养素与2019冠状病毒病:开展适应性策略研究的时机已到。
Clin Transl Allergy. 2020 Dec 3;10(1):58. doi: 10.1186/s13601-020-00362-7.